Frequencies of specific cytogenetic abnormalities in different age groups
Cytogenetic abnormality . | 60-69 y . | 70-79 y . | 80 y or older . |
---|---|---|---|
Normal karyotype | 109 (45) | 50 (45) | 2 (33) |
Unbalanced* | |||
+4 | 4 (2) | 1 (1) | 0 (0) |
-5/del(5q) | 35 (14) | 21 (19) | 1 (17) |
-5 | 10 (4) | 6 (5) | 0 (0) |
del(5q) | 25 (10) | 15 (13) | 1 (17) |
-7/del(7q) | 36 (15) | 16 (14) | 0 (0) |
-7 | 12 (5) | 11 (10) | 0 (0) |
del(7q) | 24 (10) | 5 (4) | 0 (0) |
+8 | 32 (13) | 14 (13) | 1 (17) |
Noncomplex | 17 (7) | 4 (4) | 1 (17) |
Complex | 15 (6) | 10 (9) | 0 (0) |
+11 | 13 (5) | 7 (6) | 0 (0) |
Noncomplex | 5 (2) | 1 (1) | 0 (0) |
Complex | 8 (3) | 6 (5) | 0 (0) |
+13 | 12 (5) | 4 (4) | 1 (17) |
del(13q) | 9 (4) | 6 (5) | 0 (0) |
+14 | 5 (2) | 4 (4) | 0 (0) |
-17/del(17p) | 16 (7) | 8 (7) | 1 (17) |
-17 | 8 (3) | 5 (4) | 1 (17) |
del(17p) | 8 (3) | 3 (3) | 0 (0) |
-18 | 5 (2) | 4 (4) | 0 (0) |
-20/del(20q) | 17 (7) | 6 (5) | 0 (0) |
-20 | 6 (2) | 2 (2) | 0 (0) |
del(20q) | 11 (5) | 4 (4) | 0 (0) |
+21 | 12 (5) | 5 (4) | 0 (0) |
+22 | 12 (5) | 5 (4) | 0 (0) |
Balanced† | |||
t(8;21) | 7 (3) | 5 (4) | 0 (0) |
t(11q23) | 7 (3) | 4 (4) | 0 (0) |
t(15;17) | 7 (3) | 4 (4) | 0 (0) |
inv(16)/t(16;16) | 12 (5) | 2 (2) | 0 (0) |
Other‡ | |||
abn(3q) | 9 (4) | 5 (4) | 0 (0) |
abn(12p) | 10 (4) | 14 (13) | 1 (17) |
Complex | |||
3 or more unrelated | 37 (15) | 23 (21) | 1 (17) |
5 or more unrelated | 28 (12) | 15 (13) | 1 (17) |
Total | 243 (100) | 112 (100) | 6 (100) |
Cytogenetic abnormality . | 60-69 y . | 70-79 y . | 80 y or older . |
---|---|---|---|
Normal karyotype | 109 (45) | 50 (45) | 2 (33) |
Unbalanced* | |||
+4 | 4 (2) | 1 (1) | 0 (0) |
-5/del(5q) | 35 (14) | 21 (19) | 1 (17) |
-5 | 10 (4) | 6 (5) | 0 (0) |
del(5q) | 25 (10) | 15 (13) | 1 (17) |
-7/del(7q) | 36 (15) | 16 (14) | 0 (0) |
-7 | 12 (5) | 11 (10) | 0 (0) |
del(7q) | 24 (10) | 5 (4) | 0 (0) |
+8 | 32 (13) | 14 (13) | 1 (17) |
Noncomplex | 17 (7) | 4 (4) | 1 (17) |
Complex | 15 (6) | 10 (9) | 0 (0) |
+11 | 13 (5) | 7 (6) | 0 (0) |
Noncomplex | 5 (2) | 1 (1) | 0 (0) |
Complex | 8 (3) | 6 (5) | 0 (0) |
+13 | 12 (5) | 4 (4) | 1 (17) |
del(13q) | 9 (4) | 6 (5) | 0 (0) |
+14 | 5 (2) | 4 (4) | 0 (0) |
-17/del(17p) | 16 (7) | 8 (7) | 1 (17) |
-17 | 8 (3) | 5 (4) | 1 (17) |
del(17p) | 8 (3) | 3 (3) | 0 (0) |
-18 | 5 (2) | 4 (4) | 0 (0) |
-20/del(20q) | 17 (7) | 6 (5) | 0 (0) |
-20 | 6 (2) | 2 (2) | 0 (0) |
del(20q) | 11 (5) | 4 (4) | 0 (0) |
+21 | 12 (5) | 5 (4) | 0 (0) |
+22 | 12 (5) | 5 (4) | 0 (0) |
Balanced† | |||
t(8;21) | 7 (3) | 5 (4) | 0 (0) |
t(11q23) | 7 (3) | 4 (4) | 0 (0) |
t(15;17) | 7 (3) | 4 (4) | 0 (0) |
inv(16)/t(16;16) | 12 (5) | 2 (2) | 0 (0) |
Other‡ | |||
abn(3q) | 9 (4) | 5 (4) | 0 (0) |
abn(12p) | 10 (4) | 14 (13) | 1 (17) |
Complex | |||
3 or more unrelated | 37 (15) | 23 (21) | 1 (17) |
5 or more unrelated | 28 (12) | 15 (13) | 1 (17) |
Total | 243 (100) | 112 (100) | 6 (100) |
Values indicates number of patients, with percentage in parentheses. Patients may be counted more than once due to the coexistence of more than 1 cytogenetic abnormality in the leukemic clone.
In the absence of t(8;21), t(11q23), t(15;17), or inv(16)/t(16;16).
Irrespective of karyotype complexity.
Including cases with unbalanced or balanced abnormalities.